Glioblastoma Treatment

Glioblastoma cells extend into surrounding brain tissue rather than remaining confined to a clearly defined mass. This limits the ability of surgery to remove every cancer cell without harming functional brain regions. The blood-brain barrier also restricts treatment effectiveness by limiting access to tumor cells, so local control and protection of neurological function must be balanced carefully.

Each treatment addresses a different part of the disease burden. Surgery removes visible tumor and can reduce the amount of cancer remaining, while radiation therapy and temozolomide target residual cancer cells that cannot be safely removed. Combining these modalities reflects the tumor’s infiltrative behavior and reduces reliance on any single treatment approach.

Molecular profiling adds biological information beyond tumor appearance and location. Clinicians can use these findings to refine prognosis and help guide treatment planning, including consideration of targeted approaches when appropriate. This supports a more individualized strategy, although profiling does not eliminate the challenges created by infiltrative growth, recurrence, or the blood-brain barrier.

Maximal safe resection means removing as much visible tumor as possible while preserving important neurological functions. The goal is not simply the largest operation, because aggressive removal can threaten brain regions responsible for essential abilities. Surgical planning therefore weighs tumor reduction against functional preservation and establishes a basis for subsequent treatments directed at residual disease.

Recurrence requires treatment planning that accounts for the disease’s prior course and the limitations of earlier therapy. Clinicians may consider tumor-treating fields, targeted approaches, or clinical trials, depending on the circumstances. These options reflect efforts to address recurrent disease with methods that may complement standard care or investigate therapies designed for more precise tumor control.

Glioblastoma arises within the brain, so both the tumor and its treatment can affect neurological function. Effective care therefore seeks more than tumor control: it also aims to preserve the patient’s abilities and quality of life. Neuroscience and neuro-oncology contribute by linking treatment decisions with the organization and function of affected brain tissue.